This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • The safety of sodium–glucose cotransporter-2 inhibitors in people with chronic kidney disease and type 2 diabetes

    The safety of sodium–glucose cotransporter-2 inhibitors in people with chronic kidney disease and type 2 diabetes

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe